Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care

Stock price data as of 07/02/2020

Closing price: 265.12

Support price level:	N/A
Resistance price level:	$285.00
Relative strength index (14-day RSI)	39.8
Beta	0.89

BIIB is one of this month's worst performers with a return of -11.5%, underperforming 90 percent of stocks in the S&P-100.
Volatility is forecast to fall over the next month.
BIIB is below its 200-day moving average - additional caution warranted in long positions.
Price broke below prior support level - a short-term bearish signal.

Low	High	Price as % of Range
$217.44	$342.55	43.6%

200 day	50 day	20 day	10 day
$290.77	$293.75	$275.37	$264.56

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
39.6%	35.5%	37.8%	40.5%

There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than: